|
Status |
Public on Jul 11, 2016 |
Title |
RNA-sequencing of tamoxifen resistant LY2 cells transfected with siRNA-HOXC11. |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
To assess the global effects of HOXC11 in endocrine resistant breast cancer cells we performed RNA-seq on LY2 cells which were transfected with either siRNA targeting HOXC11 (siHOXC11) or a scrambled negative control siRNA (scrHOXC11) in the presence of 4-OH-tamoxifen (10-8M). Knockdown was verified by Taq-man qRT-PCR prior to library preparation. RNA (10µg) was extracted using an Oligotex mRNA kit (Qiagen) as per manufacturer’s instructions (n=4). RNA was reverse transcribed followed by mRNA library preparation and sequencing based on a protocol outlined by Wilhelm et al., 2010. Sequencing was performed on an Illumina Genome Analyzer II (GAII) (54 million reads per sample on average).
|
|
|
Overall design |
Silencing of HOXC11 in tamoxifen resistant LY2 cells to identify putative HOXC11 target genes.
|
|
|
Contributor(s) |
Hao Y, Gaora PO, McCartan D, Young L |
Citation(s) |
26341737 |
|
Submission date |
Jul 21, 2015 |
Last update date |
May 15, 2019 |
Contact name |
Leonie Young |
Organization name |
Royal College of Surgeons, Ireland
|
Department |
Surgery
|
Lab |
Endocrine Oncology Research Group
|
Street address |
York Street
|
City |
Dublin |
ZIP/Postal code |
Dublin 2 |
Country |
Ireland |
|
|
Platforms (1) |
GPL9115 |
Illumina Genome Analyzer II (Homo sapiens) |
|
Samples (8)
|
|
Relations |
BioProject |
PRJNA290630 |
SRA |
SRP061430 |